QUEST MEDICAL STOPCOCK SVT01
Quest Medical, Inc. has revolutionized split septum technology with enhanced safety features that assist in reducing infection rates – the Q2® Technology. Integrated into most Quest products, the Q2 needleless connector’s straight, unobstructed fluid path provides high flow rates and is engineered to suppress thrombotic occlusion risks caused by disconnecting syringes and other sets. Q2 needleless connectors enable multiple activations and maintain a sterile, closed system for increased patient safety and improved outcomes.
ExoFlexTM with Q2® Technology is a new manifold designed to span departments and accommodate the need of being rigid or flexible – in seconds.
Quest Medical, Inc. revolutionizes split septum technology with enhanced safety features that assist in reducing infection control rates. The Q2® needleless connector’s straight unobstructed fluid path provides high flow rates and is engineered to suppress thrombotic occlusion risks caused by disconnecting syringes and other sets. Q2 needleless connectors enable multiple activations and maintain a sterile, closed system for increased patient safety and improved outcomes.
Quest’s manifold sets focus on safe and accurate infusion therapy delivery with minimal priming volumes and high flow rates. Our newest manifold, the ExoFlex, was designed to assist with reducing infection risks by developing a manifold that could be rigid or flexible in seconds – preventing a break in the line in between departments. Our full product line includes various tubing sizes, rigid and flexible variations, and component options to ensure your patients are kept safe.
Quest’s extension sets focus on safe and accurate infusion therapy delivery with minimal priming volumes and high flow rates. Our offerings include various tubing sizes and component options to ensure your patients are kept safe. Infection reduction was an inspiration in the development our new ExoFlex line, intended to address the needs of multiple departments while preventing a break in the line.
What do I need to know about the emergency use of the CytoSorb device?
The CytoSorb device has been authorized under an Emergency Use Authorization (EUA) for emergency use for the treatment of patients with confirmed COVID-19 who are showing certain severe symptoms (including high fever, persistent cough, developing more difficulty
breathing) indicating you are likely to get more ill within the next 1-24 hours. This device has the potential to remove substances in your blood that are not allowing the immune system to function normally.
Helps standardize, simplify & minimize post-procedure care and catheter maintenance. Promote rapid hemostasis (including on highly anticoagulated COVID patients) and prevent unnecessary dressing change.
Reduces CLABSI, prevents catheter dislodgement for the Life of the Line. Improves efficiency with catheter care & maintenance, significantly reduces nursing time compared to adhesive securement devices. Please visit our SecurAcath product page for more information.
Gamefication Code: SecurAcath
View, assess, and cannulate vasculature together with IP-ECHO™, an innovative handheld ultrasound imaging system and winner of the 2019 Good Design Award in Japan. Thanks to its user-friendly and compact design, IP-ECHO™ makes it easy to obtain vertical and horizontal “inside” views before, during, and after cannulation.
Long Peripheral Vascular Access Device (LPVAD) Completes treatment with one access reduces multiple pokes for treatment start. Please visit our Leaderflex product page for more information.
The only cyanoacrylate glue designed to secure all your venous catheters (peripheral catheters, Midline, PICC, CVC). Limits bleeding and catheter movement and forms a barrier against infection and moisture.
A new portable ECMO device coming to Canada in 2023
With a weight of less than 9 Kg and equipped with a magnetic levitation centrifugal pump, Colibrì is Eurosets brand new ECLS system designed with transport in mind. Thanks to its lightweight and minimized footprint, as well as advanced monitoring capabilities, Colibrì improves ECLS management in any clinical application. Featuring full integration with ECMOLife and a series of unique accessories that facilitate intra and extra hospital transport, Colibrì represents the next generation in the ECLS space.
CathGrip® is the only true universal catheter securement system. The device is made from our proprietary hydrocolloid that is hypoallergenic, latex free, and moves like a second skin with wear time of up to 7 days! Our skin-friendly adhesive helps prevent skin tearing and irritation unlike other acrylic based securement devices. Other products that may claim to be hydrocolloid are actually only partially hydrocolloid while the CathGrip® is 100% hydrocolloid and therefore a much gentler application.
FreeDerm® Adhesive Removal
FreeDerm adhesive remover is BioDerm’s trademark adhesive remover. Specially formulated to instantly remove hydrocolloid tapes, and bandages, FreeDerm is available in spray, ampoule, or wipe form. The FreeDerm spray bottle is ergonomically designed for customers with limited manual dexterity. FreeDerm adhesive remover is for external use only. FreeDerm can be used anywhere on the body. The formula is quick-drying and does not require washing. It is environmentally friendly and does not contain ozone-depleting chloro-fluorocarbons.
Contact one of our representatives for more information.
Territory Account Manager: Ontario
Contact Todd Townend
Please feel free to contact Todd Townend directly by phone at:
or by email clicking the button below.
Territory Account Manager: Eastern Ontario & Bermuda
Contact Justin Dube
Please feel free to contact Justin Dube directly by phone at:
or by email clicking the button below.